Carcinoma in situ of breast, intraductal

CD2_INSITU_BREAST_INTRADUCTAL_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule only females	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D05.1& Cause of death: ICD-10 — D05.1& 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints None	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D05
Name in latin: Carcinoma in situ intraductale mammae

NAME	CD2_INSITU_BREAST_INTRADUCTAL_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D051
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D051
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Carcinoma in situ of breast, intraductal based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Carcinoma in situ of breast, intraductal

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	13450	13450	-
Only index persons	13149	13149	-
Unadjusted period prevalence (%)
Whole population	0.39	0.39	-
Only index persons	0.48	0.48	-
Median age at first event (years)
Whole population	-	60.44	-
Only index persons	-	60.43	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3132	3132	-
Unadjusted period prevalence (%)	1.07	1.07	-
Median age at first event (years)	60.34	60.34	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2756: Matched controls
27559

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C50.99

ICD-10 Finland

Breast, unspecified

4844.4

323.0

424

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

899.9

323.0

453

PJA12

NOMESCO Finland

Sentinel node biopsy

4503599627370496.0

323.0

1802

HAB99

NOMESCO Finland

Other partial excision of mammary gland

60.0

323.0

573

120

H02AB02

ATC

dexamethasone; systemic

62.7

323.0

589

119

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

764.0

323.0

553

XX3DW

NOMESCO Finland

Time consuming IT work

13.3

323.0

617

584

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

4762.3

323.0

418

X76

ICPC

Malignant neoplasm breast female

+∞

323.0

306

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

+∞

323.0

449

HAB40

NOMESCO Finland

Wedge excision of mammary gland

238.3

323.0

1022

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

762.7

323.0

394

L02BA01

ATC

tamoxifen; oral

1377.3

323.0

460

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

+∞

323.0

460

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

323.0

358

115

Kela drug reimbursment

Breast cancer

+∞

323.0

1001

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

1309.4

323.0

441

HA1AA

NOMESCO Finland

X-ray mammography

38.5

323.0

1243

576

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

180.2

323.0

401

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

37.5

323.0

1044

441

C50

ICD-10 Finland

Malignant neoplasm of breast

2393.7

323.0

385

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

323.0

817

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

2385.1

323.0

384

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

176.3

323.0

784

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

72.0

323.0

427

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

323.0

1341

A04AA02

ATC

granisetron; systemic, transdermal

442.4

323.0

351

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

323.0

844

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

+∞

323.0

389

L02BG04

ATC

letrozole; oral

149.6

323.0

561

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

+∞

323.0

2754

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

323.0

727

HAC20

NOMESCO Finland

Total mastectomy

12741.6

323.0

887

TQW20

NOMESCO Finland

Tatoe

979.8

323.0

344

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

318.0

299

WX404

NOMESCO Finland

Intravenous generell anesthesy

5.6

316.7

1172

3218

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

52.1

284.6

343

WF003

NOMESCO Finland

Adjuvant radiotherapy

999.3

281.2

271

L03AA13

ATC

pegfilgrastim; parenteral

+∞

271.4

256

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

714.9

267.6

260

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

267.1

252

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

4.4

266.8

1355

4966

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

94.4

253.9

280

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

+∞

245.5

232

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

244.5

231

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

220.8

209

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

214.4

203

HA4ST

NOMESCO Finland

Labeling mammary gland pathology with sterotactic guidance

453.5

213.6

211

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

213.3

202

A04AA55

ATC

palonosetron, combinations; systemic

+∞

209.0

198

ZZR10

NOMESCO Finland

Flap of skin and muscle

282.6

207.1

209

A03FA01

ATC

metoclopramide; systemic, rectal

4.6

202.6

844

2411

ZX090

NOMESCO Finland

Other technic of radiotherapy

1012.3

195.2

189

ZX080

NOMESCO Finland

Image guided radiotherapy

1006.6

194.2

188

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

177.6

190.4

198

D05.9

ICD-10 Finland

Carcinoma in situ of breast, unspecified

646.9

186.0

182

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

9.5

182.1

398

482

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

1949.6

181.2

174

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

1921.6

179.0

172

HAE99

NOMESCO Finland

Other reconstruction of breast

149.7

172.6

182

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

169.5

161

N63

ICD-10 Finland

Unspecified lump in breast

6.5

169.2

482

870

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

168.5

160

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

+∞

165.3

157

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

155.7

148

XX1XN

NOMESCO Finland

Other isotope examination

+∞

151.4

144

HAB00

NOMESCO Finland

Excision of lesion of mammary gland

10.4

149.6

307

327

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

757.4

147.5

144

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

14.1

145.4

257

200

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

110.9

144.7

157

ZZF00

NOMESCO Finland

Graft of adipose tissue

75.6

144.4

164

A04AD12

ATC

aprepitant; systemic

1452.1

141.9

137

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

1426.4

139.8

135

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

139.8

133

Z31.5

ICD-10 Finland

Genetic counselling

8.7

138.5

316

404

D48.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Breast

13.4

138.2

249

202

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

111.6

136.5

148

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

38.8

126.1

161

D05.0

ICD-10 Finland

Lobular carcinoma in situ

429.7

124.8

124

NK6AN

NOMESCO Finland

Total body bone isotope imaging

86.1

124.5

139

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

20.2

123.6

189

100

WX402

NOMESCO Finland

General anaesthesia

3.7

120.7

621

2020

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

119.6

114

HA4MT

NOMESCO Finland

Labeling mammary gland pathology with X-ray guidance

250.7

117.8

120

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

117.5

112

L02BG06

ATC

exemestane; oral

+∞

116.5

111

WZC30

NOMESCO Finland

Teaching

4.2

115.0

495

1372

L02BG03

ATC

anastrozole; oral

1154.6

114.5

111

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

9.9

112.8

236

257

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

111.2

106

HWD00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of mammary gland

73.1

110.5

126

HA3ST

NOMESCO Finland

Removal of lesion of breast with radiological guidance

81.2

110.2

124

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

31.0

109.3

147

Z42.1

ICD-10 Finland

Follow-up care involving plastic surgery of breast

45.7

106.3

131

HA1BG

NOMESCO Finland

MRI examination of mammary gland with high intensity magnet

86.5

104.0

116

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

100.6

JN4BD

NOMESCO Finland

Extensive body CT

6.0

97.6

288

526

8500/2-C50.4

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of upper-outer quadrant of breast

+∞

95.3

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

95.3

130

Kela drug reimbursment

Malignant tumour

+∞

93.2

WX408

NOMESCO Finland

General anesthesy, balanced

2.6

92.3

864

4114

R4110

NOMESCO Finland

Physiotherapy

2.5

90.8

904

4446

WX702

NOMESCO Finland

Supraglottic ventilation device

5.2

89.0

296

621

TQB05

NOMESCO Finland

Puncture of skin of trunk

52.4

88.3

106

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

446.4

87.6

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

56.2

86.8

103

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

441.0

86.6

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

60.9

85.4

100

ZXA05

NOMESCO Finland

Left side

2.5

85.0

907

4593

HA1SA

NOMESCO Finland

Expansion mammography

117.6

84.4

L01BC06

ATC

capecitabine; oral

+∞

78.5

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

205.8

77.6

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

387.8

76.1

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.1

72.5

1233

7627

ZXA00

NOMESCO Finland

Right side

2.3

72.4

929

5070

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

4.0

72.2

311

841

1CD02

NOMESCO Finland

+∞

72.2

QB2S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in chest

75.0

70.5

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

54.1

70.5

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

70.1

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

69.0

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

182.0

68.4

HAD99

NOMESCO Finland

Other plastic operation on breast

34.0

68.0

Z51.0

ICD-10 Finland

Radiotherapy session

+∞

68.0

HAC10

NOMESCO Finland

Subcutaneous mastectomy with preservation of mamilla

345.4

67.8

HAD60

NOMESCO Finland

Replacement of prosthetic implant in breast

235.7

67.5

HAD40

NOMESCO Finland

Mastopexy

44.9

67.4

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

66.9

A04AA01

ATC

ondansetron; systemic, rectal

6.1

65.2

186

322

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

64.8

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

+∞

63.8

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

63.8

N64.9

ICD-10 Finland

Disorder of breast, unspecified

11.9

62.4

117

102

X21

ICPC

Breast sympt/compl female other

8.1

61.7

144

187

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

34.3

61.3

L03AA02

ATC

filgrastim; parenteral

60.7

60.8

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

590.2

58.9

WF049

NOMESCO Finland

Radiotherapy of metastasis

590.2

58.9

HA2AT

NOMESCO Finland

Cytology of mammary gland with ultrasound guidance

58.9

58.8

8503/2-C50.9

ICD-O-3

Noninfiltrating intraductal papillary adenocarcinoma of breast, NOS

+∞

57.5

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

57.5

HWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of mammary gland

103.9

56.0

ZSZ00

NOMESCO Finland

Primary repair operation

548.5

54.7

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

45.7

54.7

B01AB05

ATC

enoxaparin; parenteral

2.0

54.4

895

5291

WF002

NOMESCO Finland

Radical radiotherapy

41.0

54.3

HA1ST

NOMESCO Finland

Biopsy of mammary gland with sterotactic guidance

78.0

54.2

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

4.0

53.6

228

605

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

270.8

52.3

FM1FN

NOMESCO Finland

Heart function isotope examination

+∞

52.2

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

52.2

N64.5

ICD-10 Finland

Other signs and symptoms in breast

5.6

51.6

156

290

D70.82

ICD-10 Finland

Drug-induced neutropenia

25.4

51.3

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

51.2

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

16.8

49.6

HWH99

NOMESCO Finland

Other reoperation in surgery of mammary gland

59.2

49.6

N02BE01

ATC

paracetamol; systemic, rectal

2.4

49.2

2469

21597

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

49.1

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

+∞

49.1

HA6HA

NOMESCO Finland

Tomosynthesis assessment of mammary gland specimen

486.0

48.5

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

47.0

TQW99

NOMESCO Finland

Other minor procedure on skin

4.6

46.4

167

377

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

+∞

46.0

ZX120

NOMESCO Finland

Intravenous

3.2

45.6

264

894

HAD50

NOMESCO Finland

Removal of prosthetic implant from breast

23.7

45.4

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

454.9

45.4

D24

ICD-10 Finland

Benign neoplasm of breast

5.5

44.7

138

263

HA1HA

NOMESCO Finland

Tomosynthesis mammography

36.3

44.5

JN4AD

NOMESCO Finland

Body CT examination

4.9

44.3

152

326

PJW99

NOMESCO Finland

Other operation on lymphatic system

+∞

42.8

8500/3-C50.8

ICD-O-3

Infiltrating duct carcinoma, NOS, of overlapping lesion of breast

+∞

42.8

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

423.8

42.3

8500/3-C50.3

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast

+∞

41.8

ZX112

NOMESCO Finland

Subcutaneous

11.4

41.7

ZX070

NOMESCO Finland

Intensity modified radiotherapy

213.1

41.0

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

40.7

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

39.7

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

+∞

39.7

HAC25

NOMESCO Finland

Radical mastectomy

+∞

39.7

D05.7

ICD-10 Finland

Other carcinoma in situ of breast

+∞

39.7

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

39.7

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

39.7

1096

7549

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

37.6

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

+∞

37.6

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

37.6

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

55.8

37.4

A79

ICPC

Malignancy NOS

70.9

37.0

QBE30

NOMESCO Finland

Excision and repair of surgical scar in trunk

17.4

36.7

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

36.5

N60.8

ICD-10 Finland

Other benign mammary dysplasias

14.4

36.4

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

98.9

35.8

C50.39

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology

+∞

35.5

C50.93

ICD-10 Finland

Malignant tumor in other specified localization in mammary gland other or unspecified histology

+∞

35.5

Z51.5

ICD-10 Finland

Palliative care

7.3

34.6

120

D05

ICD-10 Finland

Carcinoma in situ of breast

+∞

34.4

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

177.1

33.8

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

177.1

33.8

ZZR00

NOMESCO Finland

Flap of skin

14.5

33.7

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

33.4

8500/2-C50.5

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of lower-outer quadrant of breast

+∞

33.4

R92

ICD-10 Finland

Abnormal findings on diagnostic imaging of breast

12.5

32.7

QXB05

NOMESCO Finland

Skin wound assessment, unspecified location

22.7

32.7

1XC03

NOMESCO Finland

+∞

32.3

C50.01

ICD-10 Finland

Malignant tumor of nipple and areola, ductal tumor

+∞

32.3

HAD20

NOMESCO Finland

Liposuction of breast

73.0

31.9

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

88.6

31.8

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

+∞

31.3

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

+∞

31.3

QBJ00

NOMESCO Finland

Liposuction in trunk

12.7

30.8

XX1AD

NOMESCO Finland

Other CT-examination

111.3

30.7

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

+∞

30.3

1501

Kela drug reimbursment

Palbociclib

+∞

30.3

8520/2-C50.9

ICD-O-3

Lobular carcinoma in situ, NOS, of breast, NOS

+∞

30.3

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

+∞

30.3

X26

ICPC

Fear of breast cancer female

9.9

30.1

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

8.3

30.0

HAA10

NOMESCO Finland

Biopsy of mammary gland

8.3

30.0

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

156.6

29.7

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

29.2

394

Kela drug reimbursment

Palbociclib

+∞

29.2

S18

ICPC

Laceration/cut

1.6

28.9

1086

7942

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

28.2

WF004

NOMESCO Finland

Palliative radiotherapy

146.4

27.7

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

27.1

8500/2-C50.2

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of upper-inner quadrant of breast

+∞

27.1

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

+∞

27.1

HA1CM

NOMESCO Finland

Mammary gland extensive MRI examination with 3 Tesla magnet

26.8

27.1

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

97.7

26.7

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

26.7

310

1535

HAD00

NOMESCO Finland

Augmentation mammoplasty

141.3

26.6

B01AB10

ATC

tinzaparin; parenteral

2.9

26.6

168

599

JN4CD

NOMESCO Finland

Very extensive body CT

5.8

26.6

137

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

26.1

N62

ICD-10 Finland

Hypertrophy of breast

2.8

25.8

180

682

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.1

25.2

145

488

X19

ICPC

Breast lump/mass female

5.2

25.1

155

192

Kela drug reimbursment

Fulvestrant

+∞

25.0

C50.52

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor

+∞

25.0

PD1BD

NOMESCO Finland

Extensive CT of abdominal aorta and branches

11.4

24.6

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.5

24.4

196

807

N64.8

ICD-10 Finland

Other specified disorders of breast

14.3

24.4

L01XE33

ATC

[U] palbociclib; oral

+∞

24.0

L02BA03

ATC

fulvestrant; parenteral

+∞

24.0

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

24.0

XX3AT

NOMESCO Finland

Other labeling with ultrasound guidance

41.8

23.6

TPH07

NOMESCO Finland

Cathetrisation of artery

2.4

23.5

214

942

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.4

23.1

209

919

N06AX16

ATC

venlafaxine; oral

1.8

23.1

408

2369

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

22.9

8500/2-C50.3

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of lower-inner quadrant of breast

+∞

22.9

9703

FHL

Breast resection

7.1

22.4

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

21.9

8543/3-C50.9

ICD-O-3

Paget disease and intraductal carcinoma of breast of breast, NOS

+∞

21.9

C05.1

ICD-10 Finland

Malignant neoplasm: Soft palate

+∞

21.9

C50.30

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication

+∞

21.9

HA1BA

NOMESCO Finland

Extensive X-ray mammography

10.6

21.8

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

7.4

21.4

XX1XT

NOMESCO Finland

Other puncture with other radiological guidance

20.9

21.2

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

60.5

20.9

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

20.9

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

20.9

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

211.5

20.6

128

Kela drug reimbursment

Cancers of female genital organs

110.8

20.6

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.6

20.0

147

577

L01CA04

ATC

vinorelbine; systemic

+∞

19.8

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

19.8

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

19.8

WX110

NOMESCO Finland

Local anesthesy

1.5

19.8

1757

15041

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

105.8

19.6

J01DB01

ATC

cefalexin; oral

1.5

19.3

2147

19213

N60.9

ICD-10 Finland

Benign mammary dysplasia, unspecified

7.6

18.9

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

18.8

ZZS55

NOMESCO Finland

Distension of tissue expander

100.7

18.6

M05BX04

ATC

denosumab; parenteral

2.4

17.9

156

674

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

17.9

172

780

8500/2-C50.1

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of central portion of breast

+∞

17.7

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

181.0

17.5

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

181.0

17.5

SPAT1153

SPAT

Removal of sutures

1.5

17.1

800

5968

M01AE01

ATC

ibuprofen; systemic, rectal

1.7

17.1

2435

22619

HAD10

NOMESCO Finland

Augmentation of breast using prosthesis

11.6

17.0

HA1AE

SPAT

4.0

16.8

170

XX2ET

NOMESCO Finland

+∞

16.7

C50.32

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor

+∞

16.7

L01EF01

ATC

palbociclib; oral

+∞

16.7

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

16.7

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.4

16.7

248

L02AE03

ATC

goserelin; implant

6.4

16.5

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

170.9

16.5

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

170.9

16.5

WX704

NOMESCO Finland

Intubation

2.2

16.4

179

860

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

3.8

16.2

181

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

2.1

15.8

177

860

2330A

ICD-9 Finland

Carcinoma in situ of breast and genito-urinary system, Breast

+∞

15.6

C50.1

ICD-10 Finland

Malignant neoplasm: Central portion of breast

+∞

15.6

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

+∞

15.6

R50.9

ICD-10 Finland

Fever, unspecified

1.8

15.5

268

1537

QBE00

NOMESCO Finland

Excision of loose skin or fold of skin from trunk

9.5

15.4

JN6AD

NOMESCO Finland

CT of torso and neck

13.1

15.2

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.9

15.1

157

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.8

14.9

164

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

14.6

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

+∞

14.6

C50.2

ICD-10 Finland

Malignant neoplasm: Upper-inner quadrant of breast

+∞

14.6

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

14.6

3AA13

NOMESCO Finland

+∞

14.6

8523/3-C50.9

ICD-O-3

Infiltrating duct mixed with other types of carcinoma of breast, NOS

+∞

14.6

8480/3-C50.9

ICD-O-3

Mucinous adenocarcinoma of breast, NOS

+∞

14.6

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

14.5

204

1086

WW500

NOMESCO Finland

Blood transfusion

3.7

14.5

173

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

6.8

14.2

HA5CB

NOMESCO Finland

Galactography

11.5

13.8

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

6.7

13.7

WX400

NOMESCO Finland

Inhalation anesthesy

2.4

13.7

119

512

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

13.5

8504/2-C50.9

ICD-O-3

Encapsulated papillary carcinoma of breast, NOS

+∞

13.5

8522/3-C50.9

ICD-O-3

Infiltrating duct and lobular carcinoma of breast, NOS

+∞

13.5

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

13.5

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

13.5

C50.09

ICD-10 Finland

Malignant tumor of nipple and areola, other or undeterminated histology

+∞

13.5

SPAT1269

SPAT

Other puncture and/or drainage

8.4

13.5

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

13.4

199

1081

Z80.4

ICD-10 Finland

Family history of malignant neoplasm of genital organs

13.0

12.9

HA1DA

NOMESCO Finland

Restricted mammography

50.2

12.8

QBA00

NOMESCO Finland

Puncture of skin of trunk

11.6

12.8

PJA10

NOMESCO Finland

Exploration of lymph nodes

7.2

12.7

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

70.2

12.6

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

4.8

12.5

WB303

NOMESCO Finland

Simple adjuvant therapy of malignancy with biomodifiers

+∞

12.5

8010/3-C50.9

ICD-O-3

Carcinoma, NOS, of breast, NOS

+∞

12.5

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

+∞

12.5

XX2VW

NOMESCO Finland

Radiologic consultation

8.0

12.3

HA4GT

NOMESCO Finland

Labeling mammary gland pathology with galactographic guidance

11.7

12.3

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

37.7

12.2

ZXA10

NOMESCO Finland

Bilateral

1.5

12.2

496

3557

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.0

12.1

233

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

12.1

430

2999

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

21.4

12.0

ZSZ10

NOMESCO Finland

Secondary repair operation

46.8

11.9

HA1S1

NOMESCO Finland

Photography of breasts

46.8

11.9

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.0

11.7

226

5702

FHL

Local lymph node removal (eg armpit, groin)

16.5

11.7

Z40.0

ICD-10 Finland

Prophylactic surgery for risk-factors related to malignant neoplasms

16.5

11.7

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.4

11.5

396

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

11.5

8500/2-C50.8

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of overlapping lesion of breast

+∞

11.5

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

120.5

11.4

Y83.4

ICD-10 Finland

Other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

17.9

10.7

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

11.2

10.5

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

110.4

10.4

PG1BD

NOMESCO Finland

Extensive CT angiography of tissue graft, e.g. assessment of TRAN graft

110.4

10.4

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

10.4

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

10.4

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

10.4

8543/3-C50.1

ICD-O-3

Paget disease and intraductal carcinoma of breast of central portion of breast

+∞

10.4

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

10.4

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

10.4

PJD63

NOMESCO Finland

Laparoscopic dissection of aortic lymph nodes

+∞

10.4

ZXC90

NOMESCO Finland

Use of absorbable mesh in surgery

+∞

10.4

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.1

10.4

113

546

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

2.7

10.3

250

QBE35

NOMESCO Finland

Repair of skin defect in trunk after surgery or injury

18.8

10.3

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.6

10.2

158

2555

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

10.0

593

4552

SPAT1152

SPAT

Removal of foreign body from under the skin

2.5

9.9

305

HAB20

NOMESCO Finland

Excision of lactiferous duct

6.3

9.8

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.7

9.7

361

4900

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

55.2

9.6

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

55.2

9.6

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.2

9.5

435

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

100.3

9.4

S77

ICPC

Malignant neoplasm of skin

17.6

9.4

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

9.4

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

+∞

9.4

9706

FHL

Ablation mammae, includes axillary exploration

+∞

9.4

8520/3-C50.5

ICD-O-3

Lobular carcinoma, NOS, of lower-outer quadrant of breast

+∞

9.4

8501/2-C50.9

ICD-O-3

Comedocarcinoma, noninfiltrating of breast, NOS

+∞

9.4

1742A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-inner quadrant

+∞

9.4

HA1WT

NOMESCO Finland

+∞

9.4

8520/3-C50.2

ICD-O-3

Lobular carcinoma, NOS, of upper-inner quadrant of breast

+∞

9.4

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

3.7

9.2

103

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

7.7

9.1

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

3.0

9.1

169

T85.4

ICD-10 Finland

Mechanical complication of breast prosthesis and implant

8.3

9.1

L57.0

ICD-10 Finland

Actinic keratosis

1.7

9.0

174

1033

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

9.0

177

1056

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

9.0

349

2472

X79

ICPC

Benign neoplasm breast female

24.1

8.9

WX725

NOMESCO Finland

Noninvasive ventilation

2.1

8.8

471

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.7

8.7

161

945

D70.89

ICD-10 Finland

Neutropenic splenomegaly

4.5

8.6

QB9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in torso, unspecified

7.6

8.6

QBJ99

NOMESCO Finland

Other aesthetic correction of skin of trunk

27.6

8.5

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.3

8.5

127

J05AB11

ATC

valaciclovir; oral

1.5

8.4

330

2339

J01MA12

ATC

levofloxacin; systemic

1.4

8.4

357

2571

HA1DM

NOMESCO Finland

Mammary gland very extensive MRI examination with 3 Tesla magnet

90.3

8.4

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

90.3

8.4

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

3.1

8.4

144

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.2

8.4

133

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.7

8.4

204

2994

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

8.3

8522/3-C50.4

ICD-O-3

Infiltrating duct and lobular carcinoma of upper-outer quadrant of breast

+∞

8.3

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

+∞

8.3

C50.61

ICD-10 Finland

Malignant tumor of the scapula of the mammary gland, ductal tumor

+∞

8.3

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

8.3

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

8.3

TQW40

NOMESCO Finland

Remowal of suture of skin

1.7

8.2

178

1097

L02AE02

ATC

leuprorelin; implant, parenteral

3.6

8.0

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

22.1

8.0

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

8.0

161

971

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

10.8

7.8

ZZR30

NOMESCO Finland

Flap of muscle

7.0

7.8

OAA41

NOMESCO Finland

Health check based on individual needs

45.1

7.7

D50.1

ICD-10 Finland

Sideropenic dysphagia

15.0

7.7

A02BC02

ATC

pantoprazole; systemic

1.3

7.6

1656

15034

ZZR70

NOMESCO Finland

Perforator flaps

80.3

7.4

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

7.3

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

7.3

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

+∞

7.3

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

7.3

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

7.3

PJ5YQ

NOMESCO Finland

+∞

7.3

QWF00

NOMESCO Finland

Reoperation for insufficiency of suture in plastic surgery of skin

+∞

7.3

HAF00

NOMESCO Finland

Excision of local recurrence of breast cancer

+∞

7.3

HA1DT

NOMESCO Finland

Mammary gland biopsy with MRI guidance

+∞

7.3

8520/3-C50.1

ICD-O-3

Lobular carcinoma, NOS, of central portion of breast

+∞

7.3

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

7.3

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

+∞

7.3

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

7.3

8507/3-C50.9

ICD-O-3

Invasive micropapillary carcinoma of breast of breast, NOS

+∞

7.3

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

+∞

7.3

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

7.3

WX1DG

NOMESCO Finland

Very extensive total body MRI with high intensity magnet

+∞

7.3

ZZQ70

NOMESCO Finland

Free microvascular graft of lymph nodes

+∞

7.3

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

7.3

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

7.3

RD211

NOMESCO Finland

1.9

7.3

106

576

DHB00

NOMESCO Finland

Excision of lesion of external nose

9.4

7.3

L90.5

ICD-10 Finland

Scar conditions and fibrosis of skin

3.6

7.2

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

15.8

7.2

N61

ICD-10 Finland

Inflammatory disorders of breast

2.5

7.2

221

A46

ICD-10 Finland

Erysipelas

1.5

7.2

253

1757

PJ1AN

NOMESCO Finland

Lymphsystem isotope imaging

30.1

7.1

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

30.1

7.1

N02AA05

ATC

oxycodone; systemic

1.5

7.1

225

1523

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

7.0

231

1578

L03.3

ICD-10 Finland

Cellulitis of trunk

4.9

7.0

GA5AA

NOMESCO Finland

Rib X-ray examination

7.5

6.9

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.8

6.9

154

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.3

6.8

265

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

40.1

6.8

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

40.1

6.8

ZZS50

NOMESCO Finland

Insertion of tissue expander

40.1

6.8

QB3S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in abdomen

22.6

6.7

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.6

6.6

158

1001

QWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of skin

7.8

6.6

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.0

6.5

113

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.9

6.5

440

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

5.0

6.5

C90.0

ICD-10 Finland

Multiple myeloma

70.0

6.4

A21

ICPC

Risk factor for malignancy

70.0

6.4

HAA01

NOMESCO Finland

Suture of mammary gland

70.0

6.4

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

2.0

6.3

388

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

18.0

6.3

C50.69

ICD-10 Finland

Malignant tumor of the scapula of the mammary gland, other or undeterminated histology

+∞

6.2

WB610

NOMESCO Finland

Demanding neoadjuvant therapy of tumour with antibodies

+∞

6.2

C50.3

ICD-10 Finland

Malignant neoplasm: Lower-inner quadrant of breast

+∞

6.2

C50.5

ICD-10 Finland

Malignant neoplasm: Lower-outer quadrant of breast

+∞

6.2

C57.0

ICD-10 Finland

Malignant neoplasm: Fallopian tube

+∞

6.2

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

6.2

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

+∞

6.2

L01CB01

ATC

etoposide; systemic

+∞

6.2

8503/3-C50.9

ICD-O-3

Intraductal papillary adenocarcinoma with invasion of breast, NOS

+∞

6.2

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

+∞

6.2

8211/3-C50.9

ICD-O-3

Tubular adenocarcinoma of breast, NOS

+∞

6.2

156

Kela drug reimbursment

Lapatinib

+∞

6.2

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

6.2

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

+∞

6.2

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

6.2

8480/3-C50.4

ICD-O-3

Mucinous adenocarcinoma of upper-outer quadrant of breast

+∞

6.2

8509/2-C50.9

ICD-O-3

Solid papillary carcinoma in situ of breast, NOS

+∞

6.2

8541/3-C50.9

ICD-O-3

Paget disease and infiltrating duct carcinoma of breast of breast, NOS

+∞

6.2

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

6.2

L01XE07

ATC

[U] lapatinib; oral

+∞

6.2

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

6.2

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

6.2

8503/2-C50.4

ICD-O-3

Noninfiltrating intraductal papillary adenocarcinoma of upper-outer quadrant of breast

+∞

6.2

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

6.2

152

970

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

7.0

6.2

TPX15

NOMESCO Finland

Removal of vascular injection port

10.0

6.0

N60.4

ICD-10 Finland

Mammary duct ectasia

10.0

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

434

78.56

307.65

3.3

1.0

u/ml

33.0

17.3

0.90

417

(40768793) Breast Pathology biopsy report

794

271

38.91

307.65

1.4

1.2

—

(4035726)

1014

785

18.62

307.65

1.5

1.2

—

(3002256) Pathology report gross observation

865

2312

4.79

303.60

1.4

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

292

533.58

297.89

1.1

1.0

—

(40768795) Lymph node Pathology biopsy report

171

28.20

252.02

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

118

102.14

228.20

1.1

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

577

1473

4.58

209.01

3.5

1.5

ug/l

20.0

12.6

0.28

446

1087

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1938

10897

3.04

195.36

3.8

3.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2105

12472

3.10

191.33

7.4

3.5

umol/l

9.4

10.3

4.06

2029

11567

(40768804) Tissue Pathology biopsy report

1835

10207

2.93

185.14

2.6

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

1417

7021

2.86

175.47

2.3

1.9

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2760

20460

3.94

147.52

9.3

5.4

u/l

77.4

76.0

1.23

2668

18846

(3013650) Neutrophils [#/volume] in Blood by Automated count

2156

14183

2.67

138.86

9.7

6.7

e9/l

3.6

4.0

23.46

1931

12149

(3015377) Calcium [Moles/volume] in Serum or Plasma

1536

8781

2.47

131.31

4.5

2.1

mmol/l

2.4

6.39

1371

7341

(40758558) Short blood count panel - Blood

1169

5999

2.51

125.13

6.6

4.8

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1014

5360

2.32

96.71

2.2

1.9

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

21.05

87.51

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

195

470

4.36

73.75

1.2

1.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

438

1865

2.57

64.97

1.9

2.1

g/l

0.2

8.66

420

1710

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1616

11844

1.75

50.47

5.0

4.7

mmol/l

1.2

0.87

1461

10414

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1736

13216

1.70

45.20

6.0

5.2

mmol/l

1.2

0.04

1463

11066

(3024561) Albumin [Mass/volume] in Serum or Plasma

1433

10675

1.63

38.05

4.1

3.6

g/l

36.3

36.1

0.75

1302

9731

(3042936) Bacteria identified in Isolate by Culture

514

2972

1.87

33.60

1.9

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

320

1582

2.14

32.60

2.7

1.5

u/ml

137.1

26.5

0.62

307

1504

(3023368) Bacteria identified in Blood by Culture

790

5235

1.68

32.07

3.9

3.6

—

(3003694) ABO and Rh group [Type] in Blood

845

5787

1.63

29.80

1.3

—

(3018418) pH of Serum or Plasma

1075

7828

1.57

29.13

3.9

3.1

7.4

0.61

191

1350

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

244

3.64

26.64

1.2

1.3

nmol/l

0.4

0.3

0.57

178

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2824

25969

1.89

24.68

14.2

10.3

ml/min/173m2

80.8

78.7

8.92

2491

20720

(3033658) Prothrombin time (PT) actual/Normal

834

5963

1.54

23.49

3.5

3.2

97.0

95.9

0.63

807

5776

(40758358) Immune stain study

+∞

20.85

1.0

0.0

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3040

29008

2.63

19.74

18.0

13.0

umol/l

68.1

69.6

3.89

3040

28997

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

127

535

2.43

18.86

2.9

1.9

u/ml

322.6

72.4

0.93

105

436

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3045

29143

2.61

18.44

12.9

9.3

u/l

24.0

23.9

0.11

2956

27892

(3019550) Sodium [Moles/volume] in Serum or Plasma

2991

28432

2.15

18.09

15.6

13.1

mmol/l

139.8

139.9

1.20

2938

27631

(40761511) CBC panel - Blood by Automated count

2972

28191

2.06

17.99

14.4

11.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1731

14775

1.38

17.20

3.9

3.8

mmol/l

6.5

6.6

2.27

1640

13660

(3023103) Potassium [Moles/volume] in Serum or Plasma

2991

28511

2.09

16.66

15.8

13.2

mmol/l

3.9

3.15

2933

27648

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2864

26946

1.73

16.44

14.4

11.4

mg/l

21.8

19.7

2.59

2250

20468

(3044889) 12 lead EKG panel

2177

19439

1.39

15.60

3.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1033

8269

1.37

14.51

3.6

2.6

u/l

28.7

31.0

1.65

987

7780

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

662

4927

1.44

14.20

2.9

2.2

mmol/l

2.5

1.33

576

4264

(3032080) INR in Blood by Coagulation assay

1151

9405

1.35

14.07

6.1

7.6

inr

1.1

1.2

2.89

305

2712

(3007461) Platelets [#/volume] in Blood

3093

30093

3.23

13.29

23.1

17.2

e9/l

259.6

263.6

2.99

3051

29211

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

6.32

13.28

6.9

1.4

—

(3024731) MCV [Entitic volume]

3093

30106

3.20

13.03

23.1

17.2

91.3

91.1

2.00

3070

29597

(3035941) MCH [Entitic mass]

3093

30107

3.20

13.01

23.0

17.2

30.2

0.24

3070

29598

(3026361) Erythrocytes [#/volume] in Blood

3093

30111

3.18

12.92

23.1

17.3

e12/l

4.4

14.01

3039

29110

(3010813) Leukocytes [#/volume] in Blood

3093

30113

3.18

12.88

23.2

17.3

e9/l

6.2

6.5

10.10

3043

29116

(3000963) Hemoglobin [Mass/volume] in Blood

3093

30116

3.17

12.82

23.2

17.3

g/l

131.1

133.3

22.43

3071

29613

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

356

2389

1.55

12.65

2.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

392

2691

1.52

12.55

1.5

1.7

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

475

3481

1.43

10.84

3.0

2.3

mmol/l

0.8

0.15

436

3171

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

300

2008

1.55

10.75

4.4

3.0

u/l

256.2

236.6

0.95

280

1855

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

454

2.13

10.60

1.2

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

108

547

2.01

10.33

1.5

1.7

—

(42870588) Differential panel, method unspecified - Blood

1027

8536

1.30

10.32

5.5

5.7

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1466

12767

1.28

10.18

2.3

nmol/l

81.2

80.6

0.34

1297

11359

(3019225) pH of Specimen

391

2824

1.44

9.61

4.1

3.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

269

1824

1.52

9.08

6.2

7.3

g/l

117.9

120.1

1.20

257

1749

(3003396) Base excess in Arterial blood by calculation

318

2263

1.45

8.44

5.6

6.5

mmol/l

1.1

1.4

0.80

259

1768

(3002385) Erythrocyte distribution width [Ratio]

2373

22168

1.29

8.33

19.3

13.8

13.6

0.05

2347

21628

(3027801) Oxygen [Partial pressure] in Arterial blood

315

2275

1.43

7.71

5.5

6.5

kpa

13.9

12.1

4.98

300

2159

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

315

2277

1.43

7.68

5.5

6.5

kpa

5.2

5.1

0.99

301

2166

(3019069) Monocytes/100 leukocytes in Blood

1367

12067

1.24

7.62

5.9

6.0

8.5

8.3

1.19

1270

11126

(3002030) Lymphocytes/100 leukocytes in Blood

1398

12373

1.23

7.59

5.6

5.9

27.7

29.4

6.50

1287

11334

(40768443) Skin Pathology biopsy report

183

1191

1.57

7.46

1.2

—

(3006504) Eosinophils/100 leukocytes in Blood

1357

12012

1.23

7.24

5.6

5.8

2.7

2.9

2.51

1250

11013

(3016502) Oxygen saturation in Arterial blood

279

1996

1.44

7.20

6.0

6.9

96.5

95.4

3.42

269

1910

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

310

2.09

7.02

1.2

u/l

62.7

55.6

0.44

209

(3018010) Neutrophils/100 leukocytes in Blood

1381

12278

1.22

6.98

5.5

5.6

57.0

56.3

1.28

1275

11293

(40768806) Pleura Pathology biopsy report

3.06

6.88

1.1

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

173

1133

1.56

6.88

1.3

iu/l

41.7

38.2

0.69

152

997

(3009542) Hematocrit [Volume Fraction] of Blood

2544

24145

1.29

6.84

17.1

12.8

38.5

39.2

2.83

1810

16715

(3021589) Normoblasts [#/volume] in Blood

1300

11509

1.22

6.79

9.4

8.1

e9/l

0.0

0.71

1052

9362

(3022096) Basophils/100 leukocytes in Blood

1312

11627

1.22

6.78

5.6

5.8

0.7

0.42

1211

10657

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

178

1179

1.54

6.74

6.4

7.8

0.8

0.7

3.98

178

1170

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

179

1189

1.54

6.69

6.4

7.7

1.3

1.4

1.09

179

1179

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

233

1649

1.45

6.39

1.8

1.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

763

6425

1.25

6.31

1.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

441

3469

1.32

6.30

1.9

1.7

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

510

1.77

5.98

3.2

2.4

g/l

3.5

0.02

479

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1854

17124

1.20

5.87

3.1

2.9

u/l

48.4

40.1

2.98

1696

15738

(3045142) Bone marrow Pathology biopsy report

156

2.39

5.71

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

149

989

1.53

5.63

7.5

9.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

195

2.22

5.63

3.1

3.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

572

1.68

5.39

4.9

2.2

198.7

180.9

0.91

539

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

175

2.24

5.26

3.5

1.6

nmol/l

4.2

3.7

0.20

168

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

348

2719

1.31

5.21

2.6

2.1

umol/l

9.4

6.1

1.39

297

2293

(3028308) Erythrocytes [#/volume] in Pleural fluid

120

2.51

5.20

1.2

1.5

e6/l

139675.6

80872.3

0.26

(3052851) Hemolysis interference index of Serum or Plasma

113

721

1.59

5.11

3.0

3.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

177

1243

1.45

5.11

1.8

1.6

—

(3013512) EKG study

931

8150

1.20

5.10

3.8

3.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

3.57

5.04

1.9

3.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

3.29

5.02

1.6

2.3

37.5

48.1

—

(4281824)

212

2.09

4.99

1.2

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

324

1.87

4.94

3.7

2.0

u/ml

97.7

67.6

0.31

291

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

444

3606

1.27

4.93

2.6

e6/l

4.5

0.03

224

1833

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

108

2.51

4.70

1.9

1.1

ug/l

19.8

2.8

0.44

(3036489) Thrombin time

122

809

1.53

4.69

2.5

1.8

21.1

20.9

0.15

105

676

(3018677) aPTT in Platelet poor plasma by Coagulation assay

409

3324

1.27

4.51

2.1

1.8

29.2

29.4

0.17

392

3205

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

276

2131

1.32

4.51

3.3

2.7

mmol/l

1.2

0.83

250

1785

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

148

2.24

4.50

1.1

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

303

2381

1.30

4.37

1.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

759

8658

0.84

4.31

3.5

3.8

mg/mmol

3.1

7.4

7.00

394

4849

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

618

1.57

4.24

2.6

1.9

94.9

95.7

0.13

559

(3014111) Lactate [Moles/volume] in Serum or Plasma

227

1721

1.34

4.21

5.2

5.7

mmol/l

1.2

1.3

0.42

219

1665

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

186

2.06

4.19

2.2

2.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

302

2390

1.29

4.13

1.7

1.6

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

312

2480

1.29

4.13

5.4

5.7

mmol/l

104.6

104.1

1.23

305

2430

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

360

1.74

4.09

1.3

u/l

36.3

37.5

0.09

264

(3051651) Icteric interference index of Serum or Plasma

104

2.42

4.05

3.6

4.0

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

287

2268

1.29

3.98

2.3

2.1

u/l

34.3

35.8

0.18

235

1905

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

142

1006

1.43

3.98

6.9

7.6

mmol/l

24.4

24.6

0.27

136

926

(3011412) CD3 cells [#/volume] in Blood

144

2.16

3.92

3.2

2.2

e9/l

1.3

1.2

0.20

(21494434) Karyotype in Bone marrow

138

2.19

3.89

1.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1908

17978

1.16

3.81

4.7

4.6

e6/l

1647.8

2633.5

0.48

218

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

102

2.36

3.73

1.5

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

102

2.36

3.73

1.5

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

182

1.99

3.68

1.6

1.5

u/l

2.6

5.8

1.31

(3023199) Leukocytes [#/volume] in Pleural fluid

142

2.12

3.64

1.2

1.5

e6/l

3782.8

2788.0

0.21

110

(3009214) Lutropin [Units/volume] in Serum or Plasma

256

1.81

3.54

1.1

1.2

u/l

21.4

19.2

0.39

197

(3004809) Band form neutrophils/100 leukocytes in Blood

273

1.77

3.45

2.8

3.0

1.1

0.9

0.23

209

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

139

2.10

3.43

1.4

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

126

2.15

3.41

5.6

1.1

u/ml

426.5

93.7

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

113

2.22

3.41

1.5

1.7

14.6

14.5

—

(3045788) Cell count panel - Pleural fluid

113

2.22

3.41

1.2

1.6

—

(3012516) Albumin [Mass/volume] in Urine

731

8224

0.86

3.38

2.9

3.1

mg/l

672.9

429.8

0.43

373

4532

(3000991) Gas panel - Venous blood

204

1576

1.31

3.38

6.5

7.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

182

1.93

3.33

1.3

1.2

u/l

10.7

18.0

1.79

150

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.45

3.33

1.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

142

2.05

3.26

1.4

1.3

—

(3009508) Creatinine [Moles/volume] in Urine

761

8511

0.86

3.24

2.8

3.0

mmol/l

6.4

0.05

626

7100

(3000093) Morphology [Interpretation] in Blood Narrative

164

1.96

3.19

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

236

0.34

3.16

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

215

1.82

3.13

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

262

2113

1.26

3.13

2.7

2.2

ml/min/173m2

66.5

65.8

0.11

825

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

105

2.20

3.09

1.4

1.7

—

(3022145) Colonoscopy Study observation

361

3023

1.22

3.06

1.3

—

(3019060) Gas panel - Arterial blood

174

1335

1.32

3.05

4.2

5.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

119

2.11

3.04

1.3

1.6

—

(36304419) Bacteria [Presence] in Urine

724

6447

1.16

3.02

2.8

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

401

1.58

3.02

1.2

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

401

1.58

3.02

1.2

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

196

1.85

3.02

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

256

1.73

2.97

1.9

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

607

1.46

2.92

2.0

3.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

397

1.57

2.91

2.1

1.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

228

1.76

2.91

4.7

7.1

mg/l

12.3

12.0

0.16

204

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

327

1.63

2.89

1.2

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

472

4088

1.18

2.79

2.5

2.4

e6/l

1.3

1.4

0.41

252

2309

(3037756) Immunofixation for Serum or Plasma

459

1.51

2.75

2.0

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

166

1287

1.31

2.74

5.8

7.0

mmol/l

25.1

25.0

0.16

152

1186

(3012441) Differential panel - Pleural fluid

111

2.08

2.72

1.1

1.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

441

3807

1.18

2.71

4.6

4.8

33.9

33.5

0.38

272

2484

(3002582) Erythrocytes [#/volume] in Urine

782

7065

1.14

2.63

2.9

e6/l

76.0

46.3

0.30

558

5264

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

112

824

1.37

2.63

1.7

—

(3026782) Osmolality of Urine

511

4483

1.17

2.58

2.4

2.6

mosm/kgh2o

490.4

506.4

0.99

414

3746

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

418

1.52

2.57

1.9

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

151

1167

1.31

2.57

1.4

—

(44790047)

200

1.76

2.56

1.2

1.4

—

(44790049)

200

1.76

2.56

1.2

1.4

—

(44806118)

200

1.76

2.56

1.2

1.4

—

(44790048)

200

1.76

2.56

1.2

1.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

605

6775

0.87

2.55

1.3

u/ml

2.0

1.7

0.10

139

1795

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

7.15

2.55

1.0

1.3

—

(3049717) Cytology report of Urine Cyto stain

559

1.44

2.53

2.1

1.8

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.61

2.53

1.2

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2625

26866

0.86

2.52

4.0

4.1

mmol/l

1.2

1.3

1.79

2334

24404

(3003458) Phosphate [Moles/volume] in Serum or Plasma

338

2873

1.20

2.48

4.0

4.5

mmol/l

1.0

0.33

308

2613

(3019198) Lymphocytes [#/volume] in Blood

1419

13331

1.12

2.48

5.4

5.6

e9/l

1.8

1.9

3.51

1218

11654

(3019832) Treponema pallidum Ab [Presence] in Serum

1052

0.70

2.48

1.6

1.5

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2562

26261

0.87

2.47

5.3

5.8

mmol/mol

39.1

39.5

2.41

2307

24219

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

326

1.57

2.46

5.8

4.8

iu/ml

1316.3

617.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

118

887

1.34

2.44

2.1

1.8

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.34

2.39

1.9

1.5

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

6.26

2.37

1.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.61

2.35

1.3

1.8

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

553

6193

0.87

2.32

1.6

pmol/l

82589759.2

39652906.9

0.50

448

5064

(3006315) Basophils [#/volume] in Blood

1385

13034

1.11

2.29

5.5

5.6

e9/l

0.0

1.72

1157

11163

(3026470) Cobalt [Mass/volume] in Blood

200

0.40

2.29

2.1

2.0

ug/l

1.4

4.1

—

179

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

170

1.77

2.28

2.5

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

342

1.53

2.24

1.6

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

343

1.52

2.22

1.6

1.3

—

(3035880) pH of Pleural fluid

2.34

2.21

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

164

2039

0.79

2.21

2.0

2.3

ug/l

4.9

6.2

0.53

133

1749

(3013115) Eosinophils [#/volume] in Blood

1433

13528

1.11

2.21

5.6

5.7

e9/l

0.2

4.69

1230

11795

(3001604) Monocytes [#/volume] in Blood

1376

12965

1.11

2.20

5.4

5.6

e9/l

0.5

0.6

0.14

1158

11112

(3051611) Lipemic interference index of Serum or Plasma

249

1.61

2.18

3.5

3.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

345

1.52

2.17

1.6

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

345

1.52

2.17

2.0

2.1

mg/l

16.7

24.3

0.93

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.69

2.15

2.3

1.9

—

(3035637) Corticotropin [Mass/volume] in Plasma

243

1.61

2.13

1.3

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

486

0.59

2.13

2.0

1.7

nmol/l

1.1

0.8

1.06

400

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

152

1.78

2.11

1.2

1.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

234

1954

1.21

2.10

2.2

1.5

g/l

66.7

67.1

0.36

209

1737

(40765096) Chromosome analysis panel by Banding

3.21

2.09

1.0

—

(3030467) Casts [#/volume] in Urine by Automated count

724

6600

1.13

2.08

2.9

e6/l

0.5

0.4

0.32

513

4865

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

284

1.56

2.08

2.3

1.4

—

(3007916) DNA double strand Ab [Titer] in Serum

0.00

2.06

0.0

1.2

—

112.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

274

2328

1.19

2.06

2.9

3.2

ng/l

77.4

81.1

0.40

230

1962

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

350

1.49

2.04

1.6

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

554

0.63

2.04

2.7

2.4

ug/min

126.5

72.2

0.21

322

(3025577) Chromium [Mass/volume] in Blood

193

0.41

2.04

2.4

2.1

ug/l

1.4

3.1

—

162

(3008295) Osmolality of Serum or Plasma

254

1.58

2.03

1.2

1.5

mosm/kgh2o

276.9

274.5

0.28

197

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1274

0.75

2.03

1.4

1.5

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

378

3306

1.16

2.01

2.3

2.4

g/l

2.4

0.97

334

3033

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.82

2.00

1.0

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

349

3037

1.17

1.98

2.4

2.5

20.8

22.2

1.31

292

2535

(3037467) Urinalysis macro (dipstick) panel - Urine

1955

18812

1.10

1.97

4.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.34

1.96

2.3

1.9

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

450

0.60

1.96

1.0

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

387

0.57

1.96

1.5

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

266

2268

1.19

1.93

2.2

1.7

1.8

1.46

229

1971

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2736

27832

0.87

1.92

4.5

4.7

mmol/l

1.6

4.58

2457

25555

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

371

0.56

1.90

1.4

1.2

mmol/l

6.8

7.4

0.49

268

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

174

1427

1.23

1.89

1.2

1.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

107

1.87

1.86

4.1

2.3

e6/l

483.9

463.8

0.07

(3000494) Fungus identified in Specimen by Culture

363

3188

1.16

1.84

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.21

1.84

1.6

1.9

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

351

1.46

1.83

1.7

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

222

1.58

1.82

1.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

270

1.53

1.81

1.4

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

360

1.45

1.81

1.7

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

191

1.63

1.81

3.1

2.7

59.1

58.2

0.07

127

(3024980) IgG subclass 4 [Mass/volume] in Serum

426

0.61

1.79

1.2

1.6

g/l

0.7

0.09

322

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

192

1.62

1.77

2.5

1.5

—

(3018095) Leukocytes [#/volume] in Urine

938

8747

1.10

1.76

3.5

3.4

e6/l

128.5

120.7

0.08

606

5859

(3017732) Neutrophils [#/volume] in Blood

229

1950

1.19

1.72

2.9

2.6

e9/l

3.8

3.9

0.43

174

1459

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

508

5602

0.89

1.67

1.3

u/ml

10.6

14.1

0.59

188

2157

(3017569) Oxygen content in Arterial blood

104

1.83

1.67

2.4

2.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

212

1.56

1.65

2.1

2.3

u/field

1.1

2.4

1.29

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

3.00

1.58

1.0

1.1

—

17.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

422

0.64

1.56

1.1

u/ml

0.5

1.2

0.99

154

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

176

1.60

1.54

1.4

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.43

1.53

1.1

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.43

1.53

1.1

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.43

1.53

1.1

1.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

100

1.80

1.53

1.2

1.3

mmol/l

6.5

7.0

0.22

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

671

1.29

1.48

1.8

1.5

g/l

0.0

0.00

605

(3040151) Glucose [Moles/volume] in Capillary blood

227

1.50

1.46

1.4

4.8

mmol/l

7.3

7.0

0.17

187

(3022475) Manganese [Moles/volume] in Blood

3.13

1.44

1.4

1.0

—

(21494755) Public health laboratory ask at order entry panel

169

1988

0.84

1.40

1.3

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

980

10372

0.92

1.40

3.8

4.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.90

1.39

1.3

1.1

78.3

95.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

616

1.29

1.39

1.6

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

142

1.62

1.38

2.0

2.1

u/field

0.6

2.7

3.28

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

661

1.28

1.38

1.8

1.5

g/l

0.0

0.00

603

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

324

0.61

1.37

1.3

1.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

688

1.27

1.37

2.0

1.8

ug/l

3.2

1.6

0.68

590

(3052592) Norovirus Ag [Presence] in Stool

2.20

1.37

2.0

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

539

5854

0.90

1.35

1.3

iu/ml

32.9

34.4

0.09

174

1926

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2765

28018

0.89

1.34

4.5

4.7

mmol/l

5.0

4.9

1.56

2492

25877

(40761535) Cells panel - Urine sediment

197

2276

0.86

1.32

3.0

3.6

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

283

0.60

1.31

1.2

1.5

g/l

7.0

6.7

—

201

(3025941) Bacteria identified in Stool by Culture

179

1534

1.18

1.30

1.2

—

(4034850)

951

0.78

1.30

8.4

9.3

—

(3039000) Anion gap in Blood

455

1.32

1.30

7.1

7.7

mmol/l

10.2

11.1

1.91

404

(3018572) Chloride [Moles/volume] in Blood

455

1.32

1.30

7.1

7.7

mmol/l

106.4

104.4

3.14

404

(3028192) IgG subclass 2 [Mass/volume] in Serum

282

0.60

1.30

1.2

1.5

g/l

3.0

2.8

—

198

(3024139) IgG subclass 3 [Mass/volume] in Serum

282

0.60

1.30

1.2

1.5

g/l

0.6

0.4

—

201

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

766

1.25

1.29

1.7

1.4

g/l

38.4

38.1

0.28

645

(21494815) CD4 cells/100 lymphocytes in Specimen

114

1.67

1.28

2.4

2.0

31.8

44.4

—

(3019977) pH of Arterial blood

114

1.67

1.28

4.8

2.7

7.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

118

1419

0.82

1.27

1.1

titre

523.0

198.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

353

0.65

1.27

1.0

u/ml

1.8

0.8

—

136

(3029937) Albumin [Presence] in Urine by Test strip

672

7199

0.92

1.26

3.8

4.4

estimate

0.0

1.08

217

2330

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

380

1.35

1.25

1.5

1.9

u/l

2560.6

1223.5

0.35

169

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2304

23528

0.92

1.24

4.5

pmol/l

14.9

14.8

0.69

2070

21472

(3008898) HLA-B27 [Presence]

943

0.79

1.23

1.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

637

5932

1.09

1.22

1.8

1.7

mg/l

1.0

0.01

482

4502

(3003888) Timothy IgE Ab [Units/volume] in Serum

361

0.66

1.21

1.0

u/ml

11.8

2.2

0.74

161

(3013707) Erythrocyte sedimentation rate by Westergren method

2176

21242

1.08

1.21

4.1

4.4

mm/h

12.8

12.4

0.61

1990

19653

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.72

1.21

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

140

1.58

1.20

1.9

1.5

—

(3047181) Lactate [Moles/volume] in Blood

666

1.25

1.19

5.9

6.4

mmol/l

1.1

1.3

2.30

583

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

861

0.79

1.19

1.4

1.6

iu/ml

0.2

0.1

0.46

166

(3024891) Influenza virus A+B Ag [Presence] in Specimen

533

1.28

1.18

1.1

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

106

875

1.22

1.18

5.0

5.2

0.9

0.36

820

(3026008) Bacteria identified in Urine by Culture

970

9204

1.08

1.17

3.1

3.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

114

1363

0.83

1.17

1.3

u/ml

0.2

0.9

—

129

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.78

1.16

1.0

1.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.78

1.16

1.0

1.8

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

747

0.77

1.16

1.6

1.8

—

(3028717) Thiamine [Mass/volume] in Blood

2.50

1.15

1.0

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

1.15

0.0

1.2

—

1.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

716

1.24

1.13

1.8

1.5

g/l

0.0

0.19

648

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

807

8542

0.93

1.13

1.9

2.1

u/l

134.8

158.2

1.01

743

7931

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2821

28515

0.89

1.12

5.1

5.3

mmol/l

2.9

0.08

2530

26221

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

103

1.65

1.12

2.3

—

(3019150) Specific gravity of Urine by Refractometry

560

6015

0.92

1.12

4.0

4.5

kg/l

1.0

0.29

900

(3044007) Cell count panel - Peritoneal fluid

2.00

1.12

1.4

2.7

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.00

1.12

1.0

1.3

—

(4062490)

282

0.64

1.11

1.2

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

198

1736

1.15

1.11

2.0

1.5

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

896

0.80

1.10

1.2

1.7

g/l

1.1

1.2

1.40

844

(3035320) C reactive protein [Mass/volume] in Body fluid

176

1.48

1.10

1.7

2.3

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.38

1.09

2.2

2.0

umol/l

67.4

48.6

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.38

1.09

1.0

2.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

219

0.59

1.09

1.0

mg/l

324.3

295.2

—

191

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

112

1.61

1.08

1.4

1.6

pmol/l

15.0

15.7

0.20

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

222

1966

1.14

1.08

2.7

3.0

pmol/l

4.3

4.5

1.57

192

1722

(4010399)

200

2266

0.87

1.07

1.4

1.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

105

877

1.20

1.06

4.7

5.2

1.6

0.13

818

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

109

915

1.20

1.05

1.8

1.4

g/l

3.2

3.0

0.79

699

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

237

1.40

1.04

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.96

1.03

1.3

1.2

—

(3048879) Bone marrow aspiration report

1.96

1.03

3.1

1.8

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

644

1.23

1.02

1.3

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

106

0.47

1.01

2.6

4.7

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.88

1.00

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

262

0.65

1.00

1.0

1.1

u/ml

5.9

2.6

—

(3018405) Lactate [Moles/volume] in Arterial blood

728

1.21

1.00

3.0

3.8

mmol/l

1.4

1.3

0.05

711

(3037522) Nuclear Ab [Titer] in Serum

394

4274

0.91

0.99

1.3

titre

495.1

572.8

0.39

1005

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

883

0.81

0.99

1.2

1.7

g/l

0.2

0.23

838

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

811

1.20

0.99

1.9

1.5

g/l

0.5

0.4

0.32

689

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

583

0.77

0.98

1.4

e6/l

872.1

1625.2

0.45

473

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.18

0.98

1.0

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

232

1.38

0.97

1.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

519

5554

0.92

0.96

1.4

1.3

g/l

2.2

2.3

0.92

255

3113

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

581

0.77

0.96

1.4

1.3

e6/l

49.4

22.5

0.32

446

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.96

0.0

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

160

1822

0.87

0.95

1.3

u/ml

168.5

182.8

0.13

145

1666

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

107

908

1.18

0.94

1.7

1.4

g/l

10.1

10.3

0.15

752

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

855

0.81

0.94

1.2

1.3

u/ml

2.0

5.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

865

0.82

0.93

1.2

1.3

u/ml

2.7

5.3

—

158

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

535

1.24

0.92

2.7

3.5

u/ml

0.4

0.39

327

(3008536) Aspergillus sp Ab [Presence] in Serum

2.14

0.91

4.2

2.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.67

0.91

1.1

1.0

74.4

90.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

572

1.23

0.91

3.4

3.5

mg/l

28.1

22.6

0.64

343

(3022948) Iron [Moles/volume] in Serum or Plasma

395

3653

1.09

0.91

2.3

2.4

umol/l

12.2

13.3

2.42

360

3345

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

195

0.61

0.90

1.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

195

0.61

0.90

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

719

0.80

0.90

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

2.07

0.89

1.2

1.3

57.3

52.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

103

0.48

0.89

2.2

1.6

ug/l

7.9

8.6

—

103

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

194

0.62

0.89

1.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

194

0.62

0.89

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

218

0.64

0.88

1.1

1.4

—

(4027681)

127

0.55

0.88

1.3

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

129

0.54

0.88

1.0

1.3

nmol/l

130.0

—

129

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

369

0.73

0.87

1.1

iu/ml

32.8

1762.8

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

154

1358

1.14

0.85

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.94

0.84

1.5

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

1.57

0.84

1.3

u/l

11.3

12.1

0.22

(40768441) Liver Pathology biopsy report

162

1.42

0.84

1.2

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

196

1.38

0.84

3.7

3.8

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

101

865

1.17

0.82

1.3

1.4

ug/g

305.8

307.2

0.02

489

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

202

0.64

0.82

1.3

1.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.69

0.82

1.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

328

1.28

0.82

1.3

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

1.55

0.81

1.1

iu/ml

—

2.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

176

0.62

0.79

1.2

1.3

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.82

0.79

1.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

103

1190

0.86

0.78

1.7

1.6

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

281

0.71

0.78

1.0

u/ml

8.2

3.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

108

936

1.16

0.77

3.1

3.9

mmol/l

24.7

24.5

0.26

838

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

834

1.17

0.77

3.5

mmol/l

25.2

0.05

762

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.76

0.0

2.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.70

0.75

1.1

1.4

—

(3045424) Erythrocytes [Presence] in Urine

486

1.22

0.75

1.5

1.6

—

(3020491) Glucose [Moles/volume] in Blood

175

1.37

0.74

1.2

1.5

mmol/l

6.3

6.5

0.16

110

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

351

1.26

0.74

1.2

1.3

—

(3004616) Nuclear Ab [Presence] in Serum

414

0.77

0.74

1.4

1.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

663

6310

1.06

0.74

1.5

nmol/l

22.7

22.2

0.35

539

5262

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

980

0.85

0.73

1.5

1.9

—

(3020876) Protein [Mass/time] in 24 hour Urine

172

0.64

0.73

2.0

1.4

—

0.8

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.84

0.73

2.9

1.5

—

(3029075) Extractable nuclear Ab panel - Serum

1.62

0.71

1.1

1.0

—

(3037121) Protein [Mass/volume] in Urine

757

1.17

0.71

2.9

2.4

g/l

0.2

0.4

2.78

202

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

789

8229

0.94

0.71

1.7

mmol/l

1.3

1.4

0.91

659

6879

(3044242) Glucose [Moles/volume] in Arterial blood

109

1.47

0.70

2.8

1.9

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

229

0.70

1.0

u/ml

1.6

0.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.92

0.70

1.0

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

717

0.83

0.70

2.4

2.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

111

974

1.14

0.69

1.8

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

111

974

1.14

0.69

1.8

1.4

g/l

3.7

3.8

0.15

682

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

873

8394

1.06

0.69

2.7

2.2

u/l

60.0

57.2

0.78

794

7610

(3014148) Varicella zoster virus Ab [Titer] in Serum

239

0.71

0.68

1.1

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.85

0.68

3.6

8.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

428

1.22

0.68

1.4

1.8

—

(3024869) Neuronal Ab [Presence] in Serum

1.67

0.68

1.0

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

111

976

1.14

0.68

1.8

1.4

g/l

7.5

0.02

714

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

127

1.42

0.68

1.5

1.3

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

261

0.73

0.67

1.4

1.2

—

49.4

—

(3022313) Gas panel - Capillary blood

106

930

1.14

0.67

3.4

3.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

874

0.85

0.66

1.4

1.7

—

305.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

357

1.24

0.66

1.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.79

0.66

1.0

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

260

0.73

0.66

1.4

1.2

—

54.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

277

1.27

0.65

1.3

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

968

0.86

0.65

3.1

3.4

44.3

48.1

0.74

958

(3051593) INR in Capillary blood by Coagulation assay

103

1.46

0.65

6.9

8.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.73

0.64

1.0

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

258

0.73

0.63

1.1

—

(3023410) Appearance of Cerebral spinal fluid

246

0.73

0.62

1.6

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

101

0.59

0.62

1.2

1.0

—

(4015189)

1.55

0.62

1.5

2.9

—

(3020779) Urea [Moles/volume] in Serum or Plasma

177

1612

1.10

0.62

6.1

6.9

mmol/l

8.7

9.4

0.69

165

1531

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.63

0.62

1.1

1.0

—

(3044941) Cell count panel - Synovial fluid

452

1.20

0.62

1.5

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

138

0.65

0.60

1.2

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

1.3

—

155.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

136

1509

0.90

0.60

1.7

1.8

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

0.59

0.0

1.3

—

7.0

—

(40767503) Oxygen content in Capillary blood by calculation

427

1.20

0.59

2.9

2.5

17.1

16.3

0.61

219

(3044927) Protein electrophoresis panel - Urine

288

0.76

0.59

1.0

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.58

0.0

2.3

—

(4094501)

766

0.86

0.58

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

145

1599

0.90

0.58

1.0

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

115

0.61

0.57

8.1

11.5

nmol/l

669.6

860.1

—

109

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

219

0.73

0.57

1.0

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.48

0.57

1.4

1.3

—

(3017181) Myelocytes/100 leukocytes in Blood

226

2093

1.09

0.57

3.4

3.8

1.4

0.6

2.58

386

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.51

0.56

2.2

2.7

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

311

1.22

0.55

1.3

u/ml

76.5

118.9

—

(3000285) Sodium [Moles/volume] in Blood

1.62

0.55

1.3

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

287

3063

0.93

0.55

1.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.58

0.54

1.0

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

491

0.83

0.53

1.3

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

183

1687

1.09

0.52

2.2

2.3

e9/l

69.7

72.2

0.47

128

1266

(3013139) Helicobacter pylori Ag [Presence] in Stool

210

2262

0.92

0.52

1.2

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.62

0.52

1.3

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.45

0.51

1.4

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

234

2183

1.08

0.51

1.3

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

168

0.71

0.50

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.46

0.50

3.3

7.8

—

(3000850) Epithelial cells [#/volume] in Urine

521

4990

1.05

0.50

2.4

e6/l

7.6

7.3

0.12

442

4312

(3010726) Horse dander IgE Ab [Units/volume] in Serum

313

0.80

0.49

1.0

u/ml

2.1

1.6

—

(3003181) Sodium [Moles/volume] in Urine

464

1.17

0.49

1.1

1.3

mmol/l

63.2

62.0

0.07

375

(3028433) Virus identified in Specimen by Culture

1.43

0.49

1.2

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

167

0.72

0.49

1.3

1.4

—

(3012501) Base excess in Blood by calculation

446

1.17

0.48

3.0

3.4

mmol/l

2.3

2.6

0.32

320

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.40

0.48

1.4

1.3

—

(3017704) Immunofixation for Urine

119

1.35

0.48

1.5

1.2

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

1.49

0.47

1.4

1.6

u/l

20.7

49.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.49

0.47

9.0

3.3

—

(3022217) INR in Platelet poor plasma by Coagulation assay

325

3077

1.06

0.47

20.9

22.8

inr

1.3

0.03

468

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

102

1.37

0.47

1.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

686

0.87

0.46

1.2

—

32.1

—

(4133840)

1.43

0.46

1.0

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.43

0.46

1.0

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.40

0.45

1.0

1.1

—

(1761868) Lipid panel - Serum or Plasma

928

9530

0.96

0.44

2.8

3.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

130

1415

0.92

0.43

1.7

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

208

0.77

0.43

1.0

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

1.37

0.43

5.4

2.6

e6/l

373.9

777.7

—

(3006462) Nitrate [Presence] in Urine

139

1.30

0.43

3.0

3.8

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

157

1.28

0.43

2.2

2.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

129

0.70

0.43

2.0

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

207

0.77

0.42

1.0

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

152

1639

0.92

0.42

2.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

240

1.21

0.41

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

351

1.17

0.41

1.1

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

161

0.74

0.41

1.3

—

(1616796) Gas panel - Central venous blood

423

0.85

0.41

4.5

3.3

—

(3018001) Oat IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

0.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

764

7422

1.04

0.40

2.6

2.7

ng/l

829.8

1003.0

1.06

635

6292

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

204

1.23

0.40

1.2

1.4

nmol/l

1.6

1.4

0.47

187

(3041096) Erythrocytes [Presence] in Urine by Automated

689

7102

0.96

0.40

3.3

3.5

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

0.7

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

160

0.75

0.39

1.5

1.7

—

(3005033) Fetal Nuchal fold Thickness US

160

0.75

0.39

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.41

0.39

1.1

1.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

133

1230

1.08

0.39

3.4

3.3

mmol/l

1.8

2.1

0.42

111

948

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

207

2199

0.94

0.39

1.2

iu/ml

124.4

151.1

0.45

870

(3017461) Flecainide [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

1.5

—

0.7

—

(3050794) Legionella sp Ab [Presence] in Serum

0.00

0.39

0.0

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

0.39

0.0

1.2

—

22.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

196

1.23

0.39

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

895

1.10

0.38

1.5

1.6

g/l

1.7

1.6

0.32

756

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

200

2124

0.94

0.38

2.4

2.8

ng/l

132.4

155.8

0.61

175

1932

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

831

0.90

0.38

1.6

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.35

0.38

1.2

g/l

43.5

38.4

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

113

0.71

0.37

1.0

1.4

umol/l

2.5

3.1

—

107

(3033799) Differential panel - Peritoneal fluid

1.35

0.37

1.2

2.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.35

0.37

3.6

7.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.29

0.36

6.7

2.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.29

0.36

6.7

2.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

469

1.13

0.36

3.6

3.1

nmol/l

0.7

0.8

2.19

362

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.27

0.36

5.4

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.27

0.36

5.4

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

234

2467

0.94

0.36

1.4

1.6

1.3

1.4

0.36

196

2163

(3034274) Bile acid [Moles/volume] in Serum --fasting

168

0.77

0.35

1.1

1.6

umol/l

4.6

9.7

—

108

(3009261) Glucose [Presence] in Urine by Test strip

1396

13732

1.03

0.35

3.6

3.9

estimate

0.0

1.32

224

2324

(40757373) Influenza virus identified in Isolate

1.40

0.35

1.0

1.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

264

1.18

0.34

1.8

2.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.37

0.34

1.2

1.4

ng/l

62.1

77.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

658

0.89

0.34

1.5

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

471

1.13

0.34

2.4

3.6

56.4

57.1

0.16

471

(3025130) Human papilloma virus identified in Specimen

471

1.13

0.34

1.8

1.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

205

1939

1.06

0.34

1.2

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.33

0.33

1.5

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

855

1.09

0.33

1.1

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

256

1.17

0.33

1.1

—

(3024932) HLA-DR beta [Type]

1.30

0.33

1.0

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.68

0.33

1.5

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

0.67

0.33

1.5

1.8

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.33

0.32

1.5

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

182

1924

0.94

0.32

1.3

au/ml

64.9

50.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

370

1.14

0.31

1.1

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

110

1.27

0.31

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

219

0.82

0.31

1.9

1.6

u/ml

19.2

22.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.35

0.31

1.0

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

289

2770

1.05

0.31

1.5

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

569

0.89

0.31

2.2

2.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.72

0.30

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

859

1.09

0.30

1.1

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

850

1.08

0.30

1.1

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

378

0.87

0.30

1.5

1.6

—

(3000492) Spirometry study

259

2479

1.05

0.30

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

765

0.91

0.29

1.3

1.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

1381

13613

1.03

0.29

4.9

5.2

estimate

0.0

0.80

214

2294

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

631

6151

1.03

0.29

2.2

2.3

mg/l

2.9

0.09

533

5260

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

107

0.75

0.29

1.0

1.1

miu/ml

1119.3

1707.8

—

107

(3027944) Amphetamines [Presence] in Urine

392

1.12

0.29

1.3

1.2

—

(3000330) Specific gravity of Urine by Test strip

136

1445

0.94

0.29

3.2

3.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

950

0.92

0.28

1.5

1.8

—

(3005719) IgG [Mass/volume] in Serum or Plasma

192

1826

1.05

0.28

2.8

2.5

g/l

9.8

10.5

1.01

166

1672

(4024509)

345

1.13

0.28

1.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

728

1.09

0.28

3.1

1.5

mg/l

41.6

37.2

0.09

584

(3038515) Glucose [Moles/volume] in Venous blood

460

1.11

0.28

2.3

2.9

mmol/l

7.5

7.6

0.20

447

(3034860) Kappa light chains.free [Mass/volume] in Serum

729

1.09

0.27

3.1

1.5

mg/l

26.2

38.1

5.12

587

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

201

2107

0.95

0.27

2.4

au/ml

42.7

27.0

0.53

105

(3024263) Appearance of Synovial fluid

140

1.22

0.27

1.6

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

290

0.86

0.27

1.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2751

27632

0.96

0.27

4.6

4.8

mmol/l

5.8

5.9

3.68

2446

25193

(3048689) Calprotectin [Mass/mass] in Stool

352

3641

0.96

0.27

2.0

2.1

ug/g

105.0

116.3

0.38

248

2818

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.23

0.27

1.1

—

(3020891) Body temperature

846

1.08

0.27

3.1

4.4

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

204

0.83

0.27

1.2

1.1

—

90.0

—

(3004451) EKG impression Narrative

113

1.24

0.26

1.3

—

(1002224) Polysomnography panel

1049

0.93

0.26

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

151

1593

0.95

0.26

2.4

2.8

kpa

4.4

4.5

0.24

142

1548

(3021788) Differential panel - Synovial fluid

548

1.10

0.26

1.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

234

1.16

0.26

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

234

1.16

0.26

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

234

1.16

0.26

1.2

—

(4211845)

150

1.20

0.26

3.0

3.6

—

(3003740) Influenza virus B Ag [Presence] in Specimen

319

1.13

0.26

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

0.68

0.26

1.0

1.2

pmol/l

246.4

295.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

267

0.86

0.25

1.5

36.8

37.5

0.02

148

(3002523) Influenza virus A Ag [Presence] in Specimen

320

1.13

0.25

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.23

0.25

5.4

1.6

—

(3002179) Metamyelocytes/100 leukocytes in Blood

204

1953

1.05

0.25

3.4

3.7

0.9

0.5

1.28

293

(3023511) Choriogonadotropin [Units/volume] in Urine

223

0.85

0.24

1.3

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

436

1.10

0.24

1.2

—

(3027008) Opiates [Presence] in Urine

398

1.11

0.24

1.3

1.2

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

992

0.94

0.24

1.8

2.6

0.6

0.7

0.11

946

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

982

9976

0.98

0.24

3.2

3.3

ng/l

46.9

43.1

0.10

649

6367

(3011397) Hemoglobin [Presence] in Urine by Test strip

673

6594

1.03

0.23

3.4

3.9

—

(40761536) Microorganisms panel - Urine sediment

221

2124

1.04

0.23

3.7

4.1

—

(3010421) pH of Blood

543

1.09

0.23

2.8

3.2

7.4

0.07

441

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.32

0.23

1.0

1.4

—

(3008037) Lactate [Moles/volume] in Venous blood

486

1.09

0.22

2.3

2.8

mmol/l

1.4

1.5

0.84

473

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

337

0.89

0.22

1.2

u/l

45.0

24.8

0.69

291

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

153

1.18

0.22

1.5

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

400

1.10

0.22

1.3

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

854

0.94

0.21

1.9

1.8

iu/l

4.1

4.8

0.31

307

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

252

0.87

0.21

1.2

1.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

647

6597

0.98

0.21

2.4

2.1

umol/l

7521.8

4386.2

0.87

541

5582

(3028300) Cannabinoids [Presence] in Urine

401

1.10

0.21

1.3

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.19

0.21

1.0

1.1

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

2.5

—

3.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.7

—

270.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

0.21

0.0

1.5

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

135

1.19

0.21

1.1

1.0

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

136

1296

1.05

0.21

3.5

3.3

kpa

5.2

0.10

130

1194

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

344

1.11

0.21

1.1

1.2

u/ml

296.1

285.9

0.07

216

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.21

0.0

1.3

—

2.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3014271) Vancomycin [Susceptibility]

117

1.20

0.20

3.3

3.1

—

(3024471) HLA-A [Type]

1.25

0.20

1.0

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

208

0.86

0.20

1.0

ng/l

352.5

379.4

0.19

146

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

384

1.10

0.20

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

218

0.87

0.19

1.4

1.3

u/ml

2.2

1.3

0.20

(3006184) Hemoglobin [Mass/volume] in Capillary blood

520

1.08

0.19

2.4

2.1

g/l

132.7

128.6

0.61

370

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.15

0.19

1.2

1.6

—

(3021440) Promyelocytes/100 leukocytes in Blood

209

2019

1.04

0.19

3.5

3.9

0.2

0.1

1.10

363

(3009343) pH of Capillary blood

134

1282

1.05

0.19

3.5

3.3

7.4

0.81

165

(3023420) DNA double strand Ab [Units/volume] in Serum

347

1.10

0.18

1.1

1.5

—

25.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

232

1.12

0.18

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

232

1.12

0.18

1.2

—

(3015183) Erythrocyte sedimentation rate

109

1.19

0.18

1.0

1.2

—

(4306422)

376

1.09

0.18

1.1

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

194

1.13

0.18

2.3

1.8

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.19

0.18

1.0

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

121

0.83

0.18

2.6

2.0

—

15.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

150

1442

1.04

0.17

1.7

1.5

g/l

1.2

1.3

0.21

132

1307

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

233

1.12

0.17

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

214

1.12

0.17

1.3

1.5

g/l

1.0

0.02

214

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

138

1.16

0.17

1.1

1.2

—

(3021901) Oxygen saturation in Capillary blood

339

1.09

0.17

3.1

2.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

131

0.84

0.17

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.76

0.17

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.72

0.17

1.0

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

797

1.06

0.16

1.1

u/ml

4.1

6.1

0.26

(1761482) Bacteria [#/volume] in Urine by Culture

661

1.06

0.16

3.4

4.5

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

214

0.89

0.15

1.0

ng/l

51.1

50.8

0.01

148

(3047189) Immunofixation for 24 hour Urine

1.10

0.15

3.3

1.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

149

1.14

0.15

1.1

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

149

1.14

0.15

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

119

0.84

0.15

1.2

1.7

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

197

1.12

0.15

1.0

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

718

0.95

0.15

1.5

2.2

ug/l

407.3

915.3

0.80

661

(3011288) Drugs identified in Urine by Screen method

265

0.90

0.15

1.4

1.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

381

1.08

0.15

1.3

1.2

u/ml

3.8

2.7

0.21

115

(40760892) CBC W Ordered Manual Differential panel - Blood

577

5683

1.02

0.14

3.8

4.2

—

(3034426) Prothrombin time (PT)

0.80

0.14

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

636

1.05

0.14

1.3

miu/ml

281.4

221.0

0.57

313

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

500

4922

1.02

0.13

3.3

3.5

ng/l

39.5

305.2

7.44

380

3607

(3044290) Cell count panel - Cerebral spinal fluid

531

0.94

0.13

1.3

1.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

211

0.90

0.13

1.0

ng/l

759.9

724.0

0.11

141

(3042631) Mycobacterium sp identified in Specimen

267

1.09

0.13

1.8

3.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

314

0.92

0.12

1.1

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

191

1.10

0.11

2.0

1.3

—

(3000012) Reticulocyte production index

126

0.87

0.11

1.8

1.4

—

(4146454)

308

1.07

0.11

2.1

2.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

107

1035

1.04

0.11

1.5

1.7

mg/l

2.3

3.4

0.85

741

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

322

0.93

0.11

1.1

g/l

1.4

1.5

0.26

277

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1148

11397

1.01

0.11

2.6

2.8

ug/l

103.6

95.3

0.88

1033

10491

(3011648) Oxygen content in Venous blood

167

0.90

0.10

1.8

2.4

10.2

11.2

0.51

167

(3021387) Prolactin [Units/volume] in Serum or Plasma

545

0.95

0.10

1.7

mu/l

363.1

349.8

0.07

484

(3038177) Helicobacter pylori Ab [Presence] in Serum

494

0.95

0.10

1.3

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.11

0.09

1.0

1.3

—

(3024928) Oxygen saturation in Venous blood

428

1.05

0.09

1.9

3.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

438

1.05

0.09

1.3

1.6

—

(3042733) HLA Ab [Presence] in Serum

1.04

0.09

3.6

4.9

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

411

0.95

0.09

1.3

1.1

—

(3035350) Ketones [Presence] in Urine by Test strip

1358

13507

1.01

0.09

3.5

3.9

estimate

0.0

0.50

220

2298

(3025159) Blasts/100 leukocytes in Blood

198

1942

1.02

0.09

3.4

3.9

0.1

0.3

0.37

318

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

126

1.11

0.09

1.2

1.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.07

0.08

1.0

1.1

—

(3023419) Bacteria identified in Sputum by Culture

298

0.94

0.08

2.1

2.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2671

26761

0.99

0.08

5.4

mu/l

1.9

2.1

1.34

2406

24594

(3003338) MCHC [Mass/volume]

2272

22657

1.01

0.08

20.5

15.2

g/l

330.3

330.6

1.25

2261

22519

(3015076) Soybean IgE Ab [Units/volume] in Serum

107

1.12

0.08

1.0

—

0.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.82

0.08

1.2

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.79

0.08

1.0

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.79

0.08

1.6

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

0.79

0.08

1.4

1.7

—

(3002032) Base excess in Venous blood by calculation

193

1896

1.02

0.08

2.9

3.4

mmol/l

2.3

2.1

0.29

162

1587

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

133

0.90

0.07

1.0

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

511

5062

1.01

0.07

1.8

1.7

nmol/l

1049.2

1186.6

3.00

359

3773

(3036071) Salmonella sp Ab [Titer] in Serum

1.05

0.07

1.0

1.1

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

108

1.11

0.07

2.3

1.9

u/l

213.9

200.1

0.29

108

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

782

0.97

0.07

1.6

1.4

—

(4268621)

255

1.06

0.07

2.7

2.2

—

(3045414) Leukocytes [Presence] in Urine

135

1377

0.98

0.07

1.9

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

0.84

0.06

1.8

2.6

—

(3028707) Methadone [Presence] in Urine by Screen method

193

0.93

0.06

1.1

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

240

2430

0.99

0.06

2.4

1.8

nmol/l

384.1

367.7

0.63

214

2198

(3005570) Glucose [Moles/volume] in Urine

284

0.95

0.06

1.9

2.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

533

1.03

0.06

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

722

1.03

0.05

1.8

1.6

e6/l

12752.9

10933.7

0.20

516

(36660697) Celiac disease serology panel - Serum

247

2498

0.99

0.05

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

100

1.10

0.05

4.6

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

100

1.10

0.05

4.6

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

100

1.10

0.05

4.6

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

100

1.10

0.05

4.6

1.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1192

11877

1.01

0.05

2.0

pmol/l

102.6

100.2

0.76

511

5358

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

406

1.03

0.05

1.2

nmol/l

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

427

1.03

0.04

1.1

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

252

2497

1.01

0.04

1.3

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

101

1.09

0.04

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

141

1393

1.01

0.03

1.2

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

139

0.93

0.03

1.0

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

260

1.04

0.03

2.5

2.7

mg/l

6.3

17.5

1.70

168

(3010144) Erythrocytes [#/volume] in Synovial fluid

280

0.96

0.03

1.8

1.3

e6/l

8995.3

106920.8

1.48

176

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

116

1174

0.99

0.03

2.0

2.1

u/l

39.4

40.2

0.17

102

1046

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

390

1.03

0.02

1.8

1.6

59.7

55.3

0.32

229

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

122

1.07

0.02

1.2

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

329

0.97

0.02

1.1

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

178

0.95

0.02

1.2

1.4

—

1.6

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

189

1902

0.99

0.02

2.9

3.4

kpa

5.8

5.9

0.38

181

1853

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

107

0.93

0.02

1.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

450

4488

1.00

0.01

1.4

—

(40768797) Stomach Pathology biopsy report

424

4229

1.00

0.01

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1595

15963

1.00

0.01

2.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

393

1.02

0.01

1.4

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

364

3631

1.00

0.01

5.4

6.0

—

(3016879) Cocaine [Presence] in Urine

364

1.02

0.00

1.4

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

217

2164

1.00

0.00

1.9

1.8

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

135

1.04

0.00

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

165

1.03

0.00

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

119

1.01

0.00

1.4

1.7

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

131

0.99

0.00

1.3

1.7

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

375

0.99

0.00

1.1

u/ml

5.6

3.4

0.21

160

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

114

0.96

0.00

1.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

136

1.03

0.00

1.1

—

(3022621) pH of Urine by Test strip

191

1911

1.00

0.00

3.3

3.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

374

0.99

0.00

1.4

1.2

u/ml

5.3

4.4

0.15

140

(44813793)

218

1.01

0.00

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

533

0.99

0.00

3.4

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

607

1.01

0.00

1.3

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

145

1453

1.00

0.00

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

123

1233

1.00

0.00

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

163

0.98

0.00

3.7

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

163

0.98

0.00

3.7

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

217

1.01

0.00

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

163

0.98

0.00

3.7

1.4

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

0.0

1.2

—

337.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

4.3

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

2.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.0

7.9

—

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

0.00

0.0

3.3

—

1.5

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.0

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.0

1.8

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

4.7

—

336.6

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

0.0

1.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.2

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.3

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

0.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.0

1.9

—

(3003129) Base excess in Capillary blood by calculation

0.88

0.00

3.4

1.7

mmol/l

3.7

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.00

0.00

1.0

1.1

—

(3042517) Benzodiazepines panel - Urine

0.00

0.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.91

0.00

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

270

1.00

0.00

1.5

1.4

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.91

0.00

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.88

0.00

1.0

1.1

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.91

0.00

1.1

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

300

1.00

0.00

1.5

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

150

1.00

0.00

1.3

1.7

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.01

0.00

1.0

1.1

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(3020650) Glucose [Presence] in Urine

0.97

0.00

1.2

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

150

1.00

0.00

1.0

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

140

1.00

0.00

1.2

1.5

nmol/l

1.0

1.2

—

115

(3013637) Mi-2 Ab [Presence] in Serum

0.91

0.00

1.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.92

0.00

1.2

1.1

iu/ml

144.0

166.7

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1028.0

—

(4198724)

0.93

0.00

1.0

1.2

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

2.2

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_INSITU_BREAST_INTRADUCTAL_EXALLC and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_INSITU_BREAST_INTRADUCTAL_EXALLC	1.095 [0.98, 1.22]	0.103
Birth year	0.994 [0.98, 1.0]	0.148

During the follow-up period (1.1.1998 — 31.12.2019), 1321 out of 11719 females with CD2_INSITU_BREAST_INTRADUCTAL_EXALLC died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have CD2_INSITU_BREAST_INTRADUCTAL_EXALLC.

N-year risk	Females	Males
1	0.11%	No data
5	0.651%	No data
10	1.528%	No data
15	2.962%	No data
20	4.977%	No data

Relationships between endpoints

↥

Index endpoint: CD2_INSITU_BREAST_INTRADUCTAL_EXALLC – Carcinoma in situ of breast, intraductal

GWS hits: 8

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Carcinoma in situ of breast, intraductal

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints